News | 2020.11.20
What factors facilitate the emergence of a previously unknown virus in the human population? Scientists from the CNRS, the Institut Pasteur and the IRD, in collaboration with the Institut Pasteur International Network and with several other institutions worldwide, have helped answer that question for the Zika virus. Their study sheds light on regional and continental disparities in Zika...
Document de presse | 2022.06.29
Rabies virus kills over 50,000 people each year. Although current rabies vaccines are effective, they do not offer lifelong protection and booster doses are required. Institut Pasteur scientists, in collaboration with researchers from La Jolla Institute for Immunology (LJI) in the United States, captured new high-resolution views of rabies virus, revealing potential vaccine targets. These...
Document de presse | 2023.06.06
In 2022-2023, an outbreak of monkeypox, now known as mpox (caused by the monkeypox virus or MPXV) led to 87,000 human cases in 170 countries[1]. Most cases were reported outside the usual areas in which the virus circulates. Since the outbreak began, surveillance of the virus has been stepped up in Europe, with nearly 5,000 cases being reported in France[2]. Scientists and clinicians from the...
News | 2024.03.25
The genus flavivirus includes several human pathogens, such as Zika, dengue, West Nile virus (WNV) and yellow fever virus, which persist as major threats to global public health. Yellow4FLAVI, coordinated by Giovanna Barba-Spaeth, Institut Pasteur, comprises 13 partner institutions and is supported by the European Union with with € 8 million. The aim is to use the 17D yellow fever vaccine as...
Article | 2018.05.28
This is an international call for applications for young researchers in the life sciences to lead a four-year research group (“G4”) within Institut Pasteur São Paulo
Article | 2025.03.10
For any research involving humans or animals, scientists must demonstrate compatibility with applicable ethical standards and legal requirements. At the Institut Pasteur, two bodies assess the ethical dimensions of research protocols: the Committee for Ethics in Animal Experimentation (CETEA) and the Institut Pasteur Institutional Review Board (IRB-IP).
News | 2025.07.09
Since June 6, 2025, the town of Saint-Quentin (in the Aisne département and the Hauts-de-France region) has witnessed cases of severe food poisoning, mostly in children, caused by Escherichia coli bacteria. We look back at the timeline of events, the epidemiological situation and the Institut Pasteur's role in the crisis.
Article | 2017.08.08
VACCINATIONSBefore traveling abroad, a vaccination schedule should be drawn up based on two criteria:Administrative obligation: the measures adopted by the country to protect against an infectious risk from another country, rather than the actual risks for the traveler.The actual risks for the traveler: these vary depending on the health situation of the country they are going to, the...
Article | 2020.03.27
VACCINE CANDIDATES1. Development of an animal model and accelerated development of a DNA vaccine candidate(SCARD SARS-CoV-2 project)Aims:To develop a mouse model of SARS-CoV-2 infection.This will not only enable us to evaluate the efficacy of the vaccine; it will also facilitate in vivo research on SARS-CoV-2. To evaluate the immunogenicity (ability to induce a specific immune reaction) and...
Article | 2016.12.20
The Amgen Scholars Program at Institut Pasteur will provide ten undergraduate students from European universities the opportunity to work on supervised research projects during an eight-week summer internship in Institut Pasteur.